FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901703070> ?p ?o ?g. }

• W2901703070 endingPage "58" @default.
• W2901703070 startingPage "53" @default.
• W2901703070 abstract "Background Nonvalvular atrial fibrillation (NVAF) is highly prevalent and increases the risks of cardiovascular events. In a recent subgroup analysis, treatment response was shown to vary for patients exhibiting worsening renal function (WRF) on-treatment. It is important to understand the cost-effectiveness of novel oral anticoagulant (NOAC) use in this population. Methods A cost-effectiveness analysis (CEA) was conducted using a Markov model to determine whether NOAC rivaroxaban treatment is cost-effective relative to warfarin in NVAF patients with on-treatment WRF. Input parameters were sourced from clinical literature including a multicenter clinical trial and subgroup analysis. We studied elderly US male patients at increased risk for stroke (CHADS2 score ≥ 2) undergoing treatment for NVAF and exhibiting WRF. Main outcome measures included total healthcare costs in 2017 US dollars (societal perspective), total quality-adjusted life years (QALYs), incremental cost-effectiveness ratio (ICER), and incremental net monetary benefits (INMB) per-patient. Results The remaining lifetime use of rivaroxaban is associated with 5.69 QALYs at a cost of $66,075 per patient, while warfarin produced 5.22 QALYs with costs of $78,504 per patient. At a willingness-to-pay (WTP) of $150,000 per QALY, incremental net monetary benefits (INMB) per patient are $83,590. In our population, treatment with warfarin was dominated by rivaroxaban in 99.4% of 10,000 simulations. Conclusions Rivaroxaban is likely a dominant treatment over warfarin in elderly US male NVAF patients exhibiting WRF, providing increased QALYs at a decreased overall cost. Application of these findings may require healthcare providers to predict which patients are likely to exhibit WRF." @default.
• W2901703070 created "2018-11-29" @default.
• W2901703070 creator A5055410313 @default.
• W2901703070 creator A5080378534 @default.
• W2901703070 creator A5087366513 @default.
• W2901703070 date "2019-05-01" @default.
• W2901703070 modified "2023-10-02" @default.
• W2901703070 title "Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal function" @default.
• W2901703070 cites W1238951602 @default.
• W2901703070 cites W1580691413 @default.
• W2901703070 cites W1764137733 @default.
• W2901703070 cites W1928715506 @default.
• W2901703070 cites W1991890714 @default.
• W2901703070 cites W2014783633 @default.
• W2901703070 cites W2023049016 @default.
• W2901703070 cites W2033163507 @default.
• W2901703070 cites W2055864845 @default.
• W2901703070 cites W2058056848 @default.
• W2901703070 cites W2066157763 @default.
• W2901703070 cites W2081051094 @default.
• W2901703070 cites W2085270509 @default.
• W2901703070 cites W2089657822 @default.
• W2901703070 cites W2097854437 @default.
• W2901703070 cites W2107424955 @default.
• W2901703070 cites W2112668676 @default.
• W2901703070 cites W2121156528 @default.
• W2901703070 cites W2122666241 @default.
• W2901703070 cites W2131553265 @default.
• W2901703070 cites W2136804807 @default.
• W2901703070 cites W2145327797 @default.
• W2901703070 cites W2179021985 @default.
• W2901703070 cites W2399654950 @default.
• W2901703070 cites W2473405365 @default.
• W2901703070 cites W2519603001 @default.
• W2901703070 cites W2899892054 @default.
• W2901703070 cites W59237391 @default.
• W2901703070 doi "https://doi.org/10.1016/j.ijcard.2018.11.087" @default.
• W2901703070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30518479" @default.
• W2901703070 hasPublicationYear "2019" @default.
• W2901703070 type Work @default.
• W2901703070 sameAs 2901703070 @default.
• W2901703070 citedByCount "12" @default.
• W2901703070 countsByYear W29017030702019 @default.
• W2901703070 countsByYear W29017030702020 @default.
• W2901703070 countsByYear W29017030702021 @default.
• W2901703070 countsByYear W29017030702022 @default.
• W2901703070 countsByYear W29017030702023 @default.
• W2901703070 crossrefType "journal-article" @default.
• W2901703070 hasAuthorship W2901703070A5055410313 @default.
• W2901703070 hasAuthorship W2901703070A5080378534 @default.
• W2901703070 hasAuthorship W2901703070A5087366513 @default.
• W2901703070 hasConcept C112930515 @default.
• W2901703070 hasConcept C126322002 @default.
• W2901703070 hasConcept C127413603 @default.
• W2901703070 hasConcept C177713679 @default.
• W2901703070 hasConcept C187960798 @default.
• W2901703070 hasConcept C194828623 @default.
• W2901703070 hasConcept C2776301958 @default.
• W2901703070 hasConcept C2778661090 @default.
• W2901703070 hasConcept C2779161974 @default.
• W2901703070 hasConcept C2780645631 @default.
• W2901703070 hasConcept C2908647359 @default.
• W2901703070 hasConcept C3019080777 @default.
• W2901703070 hasConcept C44249647 @default.
• W2901703070 hasConcept C515549039 @default.
• W2901703070 hasConcept C64332521 @default.
• W2901703070 hasConcept C71924100 @default.
• W2901703070 hasConcept C78519656 @default.
• W2901703070 hasConcept C99454951 @default.
• W2901703070 hasConceptScore W2901703070C112930515 @default.
• W2901703070 hasConceptScore W2901703070C126322002 @default.
• W2901703070 hasConceptScore W2901703070C127413603 @default.
• W2901703070 hasConceptScore W2901703070C177713679 @default.
• W2901703070 hasConceptScore W2901703070C187960798 @default.
• W2901703070 hasConceptScore W2901703070C194828623 @default.
• W2901703070 hasConceptScore W2901703070C2776301958 @default.
• W2901703070 hasConceptScore W2901703070C2778661090 @default.
• W2901703070 hasConceptScore W2901703070C2779161974 @default.
• W2901703070 hasConceptScore W2901703070C2780645631 @default.
• W2901703070 hasConceptScore W2901703070C2908647359 @default.
• W2901703070 hasConceptScore W2901703070C3019080777 @default.
• W2901703070 hasConceptScore W2901703070C44249647 @default.
• W2901703070 hasConceptScore W2901703070C515549039 @default.
• W2901703070 hasConceptScore W2901703070C64332521 @default.
• W2901703070 hasConceptScore W2901703070C71924100 @default.
• W2901703070 hasConceptScore W2901703070C78519656 @default.
• W2901703070 hasConceptScore W2901703070C99454951 @default.
• W2901703070 hasFunder F4320332849 @default.
• W2901703070 hasLocation W29017030701 @default.
• W2901703070 hasLocation W29017030702 @default.
• W2901703070 hasOpenAccess W2901703070 @default.
• W2901703070 hasPrimaryLocation W29017030701 @default.
• W2901703070 hasRelatedWork W1993190469 @default.
• W2901703070 hasRelatedWork W2011127570 @default.
• W2901703070 hasRelatedWork W2070372188 @default.
• W2901703070 hasRelatedWork W2540098030 @default.
• W2901703070 hasRelatedWork W2901703070 @default.
• W2901703070 hasRelatedWork W3120792855 @default.

• next